| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_745a75b0350f49480798ef5ab913bc0a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-318 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-494
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate |
2012-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be1162cb61983e0fbc3df8238b563b58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a841e3038316591e157191e87c83758e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1315440287b072f66eb2b014a907135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffa29f7562bf1a8250c751229535ff38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d0ea780a56c2b72a242f2d8e68cd829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8641b344e09c1b4db972d5d4713616ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aaf0df48d7c2b620d6adb2339cc2de7 |
| publicationDate |
2013-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20130093419-A |
| titleOfInvention |
Composition for preventing or treating skin photodamage comprising cilostazol or a pharmacologically acceptable salt thereof as an active ingredient |
| abstract |
The present invention provides a composition for preventing or treating skin photodamage, comprising cilostazol or a pharmacologically acceptable salt thereof as an active ingredient. In accordance with the present invention, cilostazol or a pharmacologically acceptable salt thereof inhibits the MAPK and AP-1 pathways, resulting in MMP-1 (metrics metalloproteinase-1) expression and type 2 percollagen synthesis by UV irradiation. It can be usefully used as a medicine, food or cosmetics for the prevention or treatment of skin photodamage caused by ultraviolet rays. |
| priorityDate |
2012-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |